Author Correction: Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases

• Partho Protim Adhikary,
• Temilolu Idowu,
• Zheng Tan,
• Christopher Hoang,
• Selina Shanta,
• Malti Dumbani,
• Leah Mappalakayil,
• Bhuwan Awasthi,
• Marcel Bermudez,
• January Weiner,
• Dieter Beule,
• Gerhard Wolber,
• Brent D G Page,
• Sarah Hedtrich

Affiliations

Partho Protim Adhikary

Faculty of Pharmaceutical Sciences, The University of British Columbia

Temilolu Idowu

Faculty of Pharmaceutical Sciences, The University of British Columbia

Zheng Tan

Faculty of Pharmaceutical Sciences, The University of British Columbia

Christopher Hoang

Faculty of Pharmaceutical Sciences, The University of British Columbia

Selina Shanta

Faculty of Pharmaceutical Sciences, The University of British Columbia

Malti Dumbani

Institute of Pharmacy, Freie Universität of Berlin

Leah Mappalakayil

Faculty of Pharmaceutical Sciences, The University of British Columbia

Bhuwan Awasthi

Faculty of Pharmaceutical Sciences, The University of British Columbia

Marcel Bermudez

Institute of Pharmacy, Freie Universität of Berlin

January Weiner

Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin

Dieter Beule

Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin

Gerhard Wolber

Institute of Pharmacy, Freie Universität of Berlin

Brent D G Page

Faculty of Pharmaceutical Sciences, The University of British Columbia

Sarah Hedtrich

Faculty of Pharmaceutical Sciences, The University of British Columbia